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Abstract
Background: In 2005, “anti-N-methyl-D-aspartate (NMDA) receptor encephalitis,” a syndrome with prominent
psychiatric symptoms, memory loss, decrease in level of consciousness, and central hypoventilation, was described
in young women with ovarian teratomas and antibodies against an antigen highly expressed in the hippocampus.
This report highlights the growing need for increased awareness among psychiatrists and other relevant medical
professionals about this under-diagnosed disorder, which should be considered in differential diagnoses.
Case presentation: A 19-year-old female with no psychiatric history presented to a district general hospital with
acute psychosis, emotional lability, memory deficit, fluctuating behavioral changes such as wandering and babbling,
and seizure. She was admitted to the hospital with a provisional diagnosis of dissociative disorder. Soon after
admission, she developed aspiration pneumonia and was intubated for mechanical ventilation. She was transferred
to our hospital for further assessment and admitted to the intensive care unit for ventilation. Laboratory test results
were unremarkable, but her EEG showed non-specific slowing with no epileptiform activity, and brain computed
tomography (CT) and MRI also showed no remarkable findings. Cerebrospinal fluid (CSF) analysis showed an
elevated white blood cell count (15 cells/hpf; 70 % lymphocytes), and blood serum and CSF samples tested positive
for NMDA receptor antibodies. Abdominal contrast-enhanced CT revealed an ovarian teratoma, which was
subsequently removed laparoscopically. Postoperative immunotherapy (steroids, intravenous immunoglobulin, and
plasmapheresis) led to gradual improvement. On day 25 of hospitalization, neuropsychological assessment
demonstrated that overall, she had returned to her premorbid level of functioning. Her condition substantially
improved over several months of cognitive rehabilitation, and she was eventually discharged on day 75.
Conclusions: Anti-NMDA receptor encephalitis, a form of autoimmune encephalitis, is commonly associated with
tumors and often misdiagnosed. Diagnosis can be confirmed by detecting NMDA receptor antibodies in the
patient’s serum or CSF. Management can be achieved with immunosuppressive therapy and tumor resection.
Keywords: Limbic encephalitis, N-Methyl-D-aspartate (NMDA) receptor encephalitis, Paraneoplastic, Misdiagnosis
Abbreviations: NMDA, N-Methyl-D-aspartate; MRI, Magnetic resonance imaging; CSF, Cerebrospinal fluid;
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Background
In 2005, “anti-N-methyl-D-aspartate (NMDA) receptor
encephalitis,” a syndrome with prominent psychiatric
symptoms, memory loss, decrease in level of conscious-
ness, and central hypoventilation, was described in
young women with ovarian teratomas and antibodies
against an antigen highly expressed in the hippocampus.
When severe, this disorder can be life-threatening, re-
quiring intensive care treatment [1]. Here, we present
the case of a 19-year-old female with anti-NMDA recep-
tor encephalitis who was first diagnosed with dissociative
disorder. The present case is noteworthy because of the
dramatic and rapid recovery from surgery she made be-
fore returning to her premorbid level of functioning.
Anti-NMDA receptor encephalitis is often misdiagnosed
as viral encephalitis, neuroleptic malignant syndrome, or
acute psychotic disorder, but treatment is specific and
delays are associated with poor outcomes. As such, this
report highlights the growing need for increased aware-
ness among psychiatrists and other relevant medical
professionals about this under-diagnosed disorder, which
should be considered in differential diagnoses.
Case presentation
A 19-year-old female with no psychiatric history pre-
sented to a district general hospital with a history of
acute psychosis, emotionally lability, memory deficit,
fluctuating behavioral changes such as wandering and
babbling, and seizure. Neurological examination did not
reveal any focal signs, and routine laboratory workup
was normal. She was admitted to the hospital with a
provisional diagnosis of dissociative disorder. Soon after
admission, she developed aspiration pneumonia and was
intubated for mechanical ventilation. At the time, re-
peated seizures occurred every 10 min. Although ancil-
lary tests including magnetic resonance imaging (MRI),
electroencephalogram (EEG), and cerebrospinal fluid
(CSF) analysis were unremarkable, the presentation of
acute psychosis in combination with recurrent seizures
and a relentless course suggested autoimmune encephal-
itis. She was transferred to our hospital for further as-
sessment and admitted to the intensive care unit (ICU)
for ventilation, where sedation was performed with pro-
pofol and dexmedetomidine. Her condition upon arrival
was as follows: Glasgow Coma Scale score 1-T-1, re-
spiratory rate 12 breaths/min on ventilation, pulse rate
80 beats/min, blood pressure 110/79 mmHg, and body
temperature 36.6 °C. There were no notable laboratory
test results, her EEG showed non-specific slowing with
no epileptiform activity, CSF analysis showed an elevated
white blood cell count (15 cells/hpf; 70 % lymphocytes),
and brain computed tomography (CT) and MRI showed
no remarkable findings (Figs. 1 and 2). Her blood serum
and CSF samples collected at the time of arrival were
sent to Dr. Dalmau’s laboratory for the measurement of
anti-NMDA receptor antibody levels. The acute presen-
tation of a severe psychotic state, with cognitive impair-
ment, fluctuating behavioral changes, and recurrent
seizures led to a clinical diagnosis of probable auto-
immune encephalitis. However, as the possibility of viral
encephalitis remained, intravenous acyclovir was initi-
ated and continued until the results of polymerase chain
reaction of CSF samples were found negative 1 week
later. Given the suspicion of anti-NMDA receptor
Fig. 1 Head CT image with no remarkable findings
Fig. 2 Brain MRI image with no remarkable findings
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encephalitis, abdominal contrast-enhanced CT (Fig. 3)
was performed, and a cystic lesion with calcification in
the pelvis was identified. The lesion was determined to
be an ovarian teratoma and was subsequently removed
laparoscopically. Postoperatively, she underwent a total
of seven plasmapheresis treatments (on days 2, 5, 7, 9,
14, 16, and 19), as well as betamethasone (first at 32 mg
and gradually decreased) and IVIg (0.4 g/kg/day) for
5 days, which led to gradual improvement. On postoper-
ative day 12, she was extubated, and the administration
of propofol and dexmedetomidine was stopped. Soon
after, the patient experienced a generalized tonic-clonic
seizure. She was treated with levetiracetam 500 mg/day
and did not experience a second generalized tonic-clonic
seizure. On day 25 of hospitalization, blood serum and
CSF samples were found positive for anti-NMDA recep-
tor antibodies, leading to a confirmed diagnosis of anti-
NMDA receptor encephalitis. Neuropsychological as-
sessment performed at that time demonstrated that
overall, she had returned to her premorbid level of func-
tioning. She showed profound improvement over several
months of cognitive rehabilitation and was eventually
discharged on day 75. After discharge, she was referred
to a cognitive rehabilitation day service facility. Since
then, she has not experienced any relapse in generalized
tonic-clonic seizures or other symptoms. The patient
returned to school 2 months after discharge.
Discussion
Anti-NMDA receptor encephalitis is a form of auto-
immune encephalitis first reported in 2007 by Dalmau et
al. of the University of Pennsylvania [2]. In October
2008, clinical data from 100 cases, gathered from around
the world, were published in Lancet Neurology [3]. This
type of encephalitis often occurs in young women at a
median age of 23 years, with a male-to-female ratio
of 9:91 [3]. Patients with this disease exhibit psychi-
atric symptoms, involuntary movement of the face
and limbs, disturbance of consciousness, and central
hypoventilation. In the early phase, patients develop
many different psychiatric symptoms, but they follow
a very similar course—gradually improving after pro-
gressing through common cold symptoms, a period of
psychiatric symptoms, an immobile period, and a
hyperactive period [4]. Some cases of anti-NMDA re-
ceptor antibodies identified in patients with purely
psychiatric disorders have also been reported [5, 6].
The complication rate for teratomas is reported to be
59, and 95 % of all teratomas are ovarian teratomas;
additionally, mediastinal teratoma, orchioncus, small
cell lung carcinoma, and other tumors have been re-
ported [7]. Definitive diagnosis is possible when anti-
NMDA receptor antibodies are detected in the CSF
and blood serum.
We present a case of successful treatment of paraneo-
plastic anti-NMDA receptor encephalitis. In this case, a
19-year-old woman was admitted following an abrupt-
onset episode of emotional lability, memory deficit,
fluctuating behavioral changes such as wandering and
babbling, and seizure. Although routine physical and
laboratory tests were normal, the appearance of fluctua-
tions in mental status combined with repeated general-
ized seizures, results of spinal fluid examination with an
elevated number of lymphoid cells, and slow activity in
EEG initially led to a diagnosis of suspected limbic en-
cephalitis. The current management guidelines for this
disorder advocate early detection and removal of the
teratoma [1]. In our case, the discovery of a teratoma by
abdominal CT suggested a diagnosis of anti-NMDA re-
ceptor encephalitis, and the teratoma was urgently re-
moved even before the results of anti-NMDA receptor
antibodies in CSF were obtained.
In general, the majority of patients present with a
combination of behavioral, cognitive, and motor symp-
toms, as well as speech disorder, seizures, and decreased
level of consciousness, with psychiatric symptoms often
predominating in the early phase. Such a presentation
often leads patients to first seek psychiatric evaluation
and treatment, leading to a crucial delay in diagnosis
and immunotherapy [8]. Moreover, a recent large
cohort-based study revealed that 4 % of patients pre-
sented with isolated psychiatric episodes (pure psychi-
atric symptoms without neurological involvement) [9].
In this cohort, brain MRI, EEG, and CSF studies were
abnormal in 33, 90, and 79 % of patients, respectively.
Fig. 3 Abdominal CT image showing a right cystic adnexal mass
with an internal focus of fat and high-attenuation material, suggesting
an ovarian teratoma (red circle)
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Moreover, results of these ancillary tests in patients with
isolated psychiatric episodes were similar to the cohort
population at large. As early recognition of these epi-
sodes and initiation of appropriate therapy was shown to
be an important prognostic factor, the authors recom-
mended that, in patients with new-onset psychosis, his-
tory of encephalitis, subtle neurological symptoms, and
abnormal, albeit non-specific, CSF, EEG, or MRI find-
ings, prompt screening should be performed for NMDA
receptor antibodies and ovarian teratomas when applic-
able [9]. In the present case, although the patient was
first diagnosed with dissociative disorder at a district
general hospital, prompt screening for NMDA receptor
antibodies, early detection and removal of the ovarian
teratoma, and immunotherapy following surgery were
adequately performed at our hospital after transfer.
Recent data suggest that over half of patients respond
to first-line immunotherapy (steroids, intravenous im-
munoglobulin, and plasmapheresis, alone or in combin-
ation) within 4 weeks. Moreover, second-line treatment
(rituximab and/or cyclophosphamide) is usually effective
when first-line therapies fail. When relevant, rapid re-
moval of an associated neoplasm is warranted and pos-
sibly reduces the future risk of relapse, which may
exceed 10 % during the first 2 years. Despite optimal
treatment, the recovery process can continue for over
18 months [1]. A prolonged hospital stay is to be ex-
pected with a reported median hospitalization period of
2.5 months (range, 2 to 14 months) [4]. These interven-
tions resulted in marked improvements over the course
of several months in this case. Notably, neuropsycho-
logical assessment performed on day 25 of hospitalization
demonstrated that overall, she had returned to her pre-
morbid level of functioning. The present case represents a
relatively short time to recovery relative to that of previous
reports [2].
This patient underwent general anesthesia for her sur-
gery. In general, preoperative measures to prevent deep
vein thrombosis are required because the duration of
sedation under mechanical ventilation can sometimes be
quite long in these patients. In addition, during surgery,
the use of ketamine and nitrous oxide should be avoided,
as they inhibit NMDA receptors (NMDAR) [10] and
volatile anesthetics exhibit a wide range of NMDAR in-
hibitory potencies and immobilizing activities. By con-
trast, propofol is less likely to produce anesthetic effects
through an NMDAR-dependent mechanism. This is be-
cause propofol anesthetizes via enhancing GABA-ergic
transmission. Therefore, propofol may be a more appro-
priate anesthetic for such patients [10]. Postoperatively,
many patients require mechanical ventilation to address
respiratory depression and seizures.
In summary, the present case illustrates that, while
anti-NMDA receptor encephalitis is an unfamiliar
condition to many physicians, the inclusion of this
disorder in differential diagnoses is critical, as prompt
initiation of immunotherapy and tumor removal, if ap-
propriate, could dramatically improve outcomes.
Conclusions
Anti-NMDA receptor encephalitis is an often misdiag-
nosed form of autoimmune encephalitis commonly
associated with tumors. Detection of NMDA receptor
antibodies in the patient’s serum or CSF is necessary for
a confirmed diagnosis, and management is achieved with
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